Fig. 3.

FDFT1 Enhances Expression of stemness marker and Drug Resistance in glioblastoma cells. (A) Protein expression levels of CD133 following the knockdown of FDFT1. (B) Protein expression levels in response to FDFT1 knockdown or overexpression. (C) A representative flow cytometry apoptosis assay result showing sensitivity of U87 cells to TMZ after FDFT1 knockdown or overexpression. (D) Statistical analysis of apoptosis induced by TMZ. Abbreviations: NC, negative control using scrambled siRNA; KD, knockdown; OE, overexpression; TMZ, temozolomide; **, p < 0.01